Follow The Filings

MBX MBX Biosciences

MBX Biosciences earnings company data as of 6:18 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MBX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MBX insider trades
  • $526K bought by 1 insider
  • None no sales outside a trading plan
  • $2.7M sold by 1 insider under 10b5-1 plans
  1. Salomon Azoulay Chief Medical Officer
    Planned sale
    $2.7M 70,003 shares at $38.36 83% of stake
    Traded May 8 Filed May 11
    ↗
  2. P. Kent Hawryluk CEO
    Buy
    $526K 18,500 shares at $28.41 +4% to stake
    Traded Mar 13 Filed Mar 16
    ↗
  3. P. Kent Hawryluk CEO
    Buy
    $273K 20,000 shares at $13.64 +4.5% to stake
    Traded Oct 20, 2025 Filed Oct 21, 2025
    ↗
  4. Steven L. Hoerter Director
    Buy
    $265K 20,000 shares at $13.25 New stake
    Traded Oct 17, 2025 Filed Oct 20, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 stock grants, 4 option exercises, and 3 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02,5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.